NxStage Stock Receives a Third Buy Rating in a Row

BTIG, Piper Jaffray, and Northland Securities have all assigned Buy ratings to NxStage, which trades as NXTM on the NASDAQ. In the past quarter, more insiders have been buying the stock.

Read the full article » | Posted 04-12-2017

Related Articles

• Baxter Empowers has Tools for Healthcare Professionals Posted 11-15-2023
• Baxter Highlights New Sharesource Data at ASN Kidney Week Posted 11-15-2023
• Trace Medical to Distribute Tablo Machines to Home Medical Equipment Providers Posted 11-15-2023
• Premier Dialysis Uses One Long Overnight Icodextrin PD Exchange Posted 10-13-2023